Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis.
暂无分享,去创建一个
N. Lydon | M. Di Nicola | C. Gambacorti-Passerini | M. Fanelli | A. Biondi | E. Marchesi | A Biondi | E. Pogliani | C Gambacorti-Passerini | G. Corneo | L. Mologni | E Pogliani | P. le Coutre | C. Bertazzoli | D. Belotti | P le Coutre | N B Lydon | L Mologni | M Fanelli | C Bertazzoli | E Marchesi | M Di Nicola | G M Corneo | D Belotti | P. L. Coutre | E. M. Pogliani | Nicholas B. Lydon | A. Biondi | Gianmarco Corneo | Carlo Gambacorti-Passerini | Massimo Di Nicola | Daniela Belotti | E. Pogliani
[1] P. Pandolfi,et al. Human CD4 lymphocytes specifically recognize a peptide representing the fusion region of the hybrid protein pml/RAR alpha present in acute promyelocytic leukemia cells. , 1993, Blood.
[2] R. Salgia,et al. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway. , 1996, Oncogene.
[3] R. Warnke,et al. Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis. , 1989, Blood.
[4] I. Miyoshi,et al. Establishment of a Ph1 chromosome-positive cell line from chronic myelogenous leukemia in blast crisis. , 1983, International journal of cell cloning.
[5] Susan M. Watanabe,et al. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity , 1984, Cell.
[6] H. Koeffler,et al. Tumor necrosis factor α: Posttranscriptional stabilization of WAF1 mRNA in p53‐deficient human leukemic cells , 1996 .
[7] P. Pelicci,et al. Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the pml/RAR alpha protein. , 1993, Blood.
[8] R. Ferrell,et al. Mutational inactivation of the p53 gene in the human erythroid leukemic K562 cell line. , 1993, Leukemia research.
[9] T. Barbui,et al. Detection of ALL-1/AF4 fusion transcript by reverse transcription-polymerase chain reaction for diagnosis and monitoring of acute leukemias with the t(4;11) translocation. , 1993, Blood.
[10] B. Calabretta,et al. Inhibition of protooncogene expression by antisense oligodeoxynucleotides: biological and therapeutic implications. , 1991, Cancer research.
[11] T. Miyazaki,et al. Establishment and characterization of a new Ph1-positive chronic myeloid leukemia cell line MC3 with trilineage phenotype and an altered p53 gene. , 1995, Leukemia & lymphoma.
[12] G. Daley,et al. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. , 1990, Science.
[13] J. Griffin,et al. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl , 1996, The Journal of experimental medicine.
[14] O. Witte,et al. Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene , 1995, Cell.
[15] C. Melief,et al. Recognition of BCR-ABL positive leukemic blasts by human CD4+ T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide. , 1996, Blood.
[16] C. Sawyers,et al. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. , 1996, Oncogene.
[17] E. Jaffe,et al. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.
[18] E. Erba,et al. Lysis by activated lymphocytes of melanoma and small cell lung cancer cells surviving in vitro treatment with mafosfamide. , 1987, Cancer research.
[19] K. Kishi,et al. A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors. , 1985, Leukemia research.
[20] D. Cortez,et al. Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis , 1995, Molecular and cellular biology.
[21] G. Nilsson,et al. Characterization of a Human Basophil‐Like Cell Line (LAMA‐84) , 1996, Scandinavian journal of immunology.
[22] Kees Stam,et al. Structural organization of the bcr gene and its role in the Ph′ translocation , 1985, Nature.
[23] A. Palumbo,et al. Establishment of a Ph1-positive human cell line (BV173). , 1983, Journal of the National Cancer Institute.
[24] Jürg Zimmermann,et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells , 1996, Nature Medicine.
[25] C. Lozzio,et al. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. , 1975, Blood.
[26] D. Green,et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl , 1995, The Journal of experimental medicine.
[27] T. Meyer,et al. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. , 1996, Cancer research.
[28] M. Di Nicola,et al. Combined negative and positive selection of mobilized CD34+ blood cells , 1996, British journal of haematology.